Structured evidence table for Vitamin C Skin Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Vitamin C Skin Randomized Trial | It creates microchannels in the skin with fine needles and may help regulate increased melanocyte stimulation and vascular abnormalities [,]. | 3 | Dhaliwal Sharon (2026) | Exploring the Effectiveness, Tolerability, and Safety of the Adjunctive Use of Microneedling With Tranexamic Acid in the Treatment of Melasma |
| Vitamin C Skin Randomized Trial | Its primary mechanism is microtrauma induced activation of wound healing pathways, resulting in increased collagen and elastin production and epidermal thickening [,,]. | 3 | Dhaliwal Sharon (2026) | Exploring the Effectiveness, Tolerability, and Safety of the Adjunctive Use of Microneedling With Tranexamic Acid in the Treatment of Melasma |
| Vitamin C Skin Randomized Trial | This scoping review aims to consolidate and summarize the available clinical evidence to support informed and individualized treatment decision making in melasma management. | 3 | Dhaliwal Sharon (2026) | Exploring the Effectiveness, Tolerability, and Safety of the Adjunctive Use of Microneedling With Tranexamic Acid in the Treatment of Melasma |
| Vitamin C Skin Randomized Trial | 1 2 3 4 1 5 5 6 7 Melasma is a skin disorder that manifests with patches of brownish‐gray hyperpigmentation, commonly on sun‐exposed areas of the face. | 3 | Dhaliwal Sharon (2026) | Exploring the Effectiveness, Tolerability, and Safety of the Adjunctive Use of Microneedling With Tranexamic Acid in the Treatment of Melasma |
Source documents